BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22807498)

  • 1. Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells.
    Bougen NM; Steiner M; Pertziger M; Banerjee A; Brunet-Dunand SE; Zhu T; Lobie PE; Perry JK
    Endocr Relat Cancer; 2012 Oct; 19(5):625-44. PubMed ID: 22807498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C.
    Bougen NM; Yang T; Chen H; Lobie PE; Perry JK
    Oncol Rep; 2011 Aug; 26(2):487-93. PubMed ID: 21567106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.
    Pandey V; Perry JK; Mohankumar KM; Kong XJ; Liu SM; Wu ZS; Mitchell MD; Zhu T; Lobie PE
    Endocrinology; 2008 Aug; 149(8):3909-19. PubMed ID: 18450952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
    Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.
    Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK
    Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis.
    Zhu Z; Mukhina S; Zhu T; Mertani HC; Lee KO; Lobie PE
    Oncogene; 2005 May; 24(23):3774-85. PubMed ID: 15782123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
    Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
    Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.
    Wu ZS; Yang K; Wan Y; Qian PX; Perry JK; Chiesa J; Mertani HC; Zhu T; Lobie PE
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1619-29. PubMed ID: 21849525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor.
    Kaulsay KK; Zhu T; Bennett W; Lee KO; Lobie PE
    Endocrinology; 2001 Feb; 142(2):767-77. PubMed ID: 11159849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
    Harada T; Harada K; Ueyama Y
    Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model.
    Evans A; Jamieson SM; Liu DX; Wilson WR; Perry JK
    Cancer Lett; 2016 Aug; 379(1):117-23. PubMed ID: 27241667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.
    Mukhina S; Mertani HC; Guo K; Lee KO; Gluckman PD; Lobie PE
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15166-71. PubMed ID: 15353581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone.
    Zhu T; Starling-Emerald B; Zhang X; Lee KO; Gluckman PD; Mertani HC; Lobie PE
    Cancer Res; 2005 Jan; 65(1):317-24. PubMed ID: 15665309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival.
    Mertani HC; Zhu T; Goh EL; Lee KO; Morel G; Lobie PE
    J Biol Chem; 2001 Jun; 276(24):21464-75. PubMed ID: 11297545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine human growth hormone enhancement of human mammary carcinoma cell spreading is Jak2 dependent.
    Kaulsay KK; Mertani HC; Lee KO; Lobie PE
    Endocrinology; 2000 Apr; 141(4):1571-84. PubMed ID: 10746665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells.
    Chen YJ; Zhang X; Wu ZS; Wang JJ; Lau AY; Zhu T; Lobie PE
    Cancer Lett; 2015 Sep; 365(2):182-9. PubMed ID: 26070963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone.
    Tang JZ; Kong XJ; Banerjee A; Muniraj N; Pandey V; Steiner M; Perry JK; Zhu T; Liu DX; Lobie PE
    Endocrinology; 2010 Sep; 151(9):4133-45. PubMed ID: 20668024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization of EMT6 mammary carcinoma cells by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide.
    Haykal J; Fernainy P; Itani W; Haddadin M; Geara F; Smith C; Gali-Muhtasib H
    Radiother Oncol; 2008 Mar; 86(3):412-8. PubMed ID: 18006096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.